Summary

Revenue : 000,000 M USD
Finance : 000,000 M USD
Earning Cap : 000,000 M USD
Invest : 000,000 M USD
R & D : 0000 People
Growth : 00% AGR

DIGDAL CAP

Overview

General Introduction Nanjing Xinjiekou Department Store Co., Ltd. (referred to as "Nanjing Xinbai") was founded in August 1952 and officially listed on the Shanghai Stock Exchange in 1993, becoming the first commercial listed company in Nanjing with stock code 600682. It is a "Chinese time-honored brand" enterprise and currently serves more than 25000 global employees. Since 2016, Nanjing Xinbai has actively participated in the construction of "Healthy China 2030" and built a health industry ecosystem centered around the human life cycle, with "hope for life, medical care for illness, and care for the elderly". As of now, the health and elderly care business services cover over 20 million Chinese users and 1 million Israeli users, making it a larger health and elderly care group in China and Israel; With associated reserves exceeding 1.6 million, it has large-scale umbilical cord blood bank resources both domestically and internationally; Provenge, a cellular immunotherapy drug approved by the US FDA, is a marketed cellular immunotherapy drug for the treatment of prostate cancer. It is recommended as a first-line medication for the treatment of advanced prostate cancer by the National Cancer Guidelines and is fully covered by major medical insurance policies in the United States. At present, Nanjing Xinbai integrates happy life and health protection through four core businesses: biological immunity, cord blood stem cell storage and application, healthy elderly care, and modern commerce, helping people achieve a healthy and happy life!.
Headquarter Nanjing
Establish Date 5/14/1991
Listed Code 600682.SH
Listed Date 10/18/1993
Chairman Zhai Lingyun.
CEO Zhang Xuan.
Website www.cenbest.com

Buy Premium Now

$15/month billed now

View the full stack of insights immediately

Or 7 Days Free Charge for Trial

See feature available in the Trial and Premium

See our Solution and Servicetrial.solutionservice.trial

See our Uniquness and Value deliveringtrial.solutionservice.trial